Latest Articles
About This Stock
More About This Stock
Read
Read
Read
Actavis Strikes $66 Billion Deal For Botox Maker Allergan
Article By:
Zacks Investment Research
Tuesday, November 18, 2014 5:01 PM EDT
With the Allergan acquisition, Actavis will be able to strengthen its global presence especially in Canada, Europe and Southeast Asia and other high-value growth markets like China, India, the Middle East and Latin America.
Allergan Beats On Earnings, Revenues; Valeant Raises Offer
Article By:
Zacks Investment Research
Monday, October 27, 2014 8:29 AM EDT
Allergan’s presence across different segments will help maintain growth.
Active Stocks: Amgen, Alkermes, Nanosphere, Biogen Idec, Regulus Therapeutics
Article By:
BioMedReports
Wednesday, October 22, 2014 5:42 PM EDT
U.S. stocks turned lower in afternoon trading on Wednesday, with major indexes erasing earlier gains as a shooting at the Canadian parliament unnerved investors and Boeing and Biogen sold off following results.